Catalyst Wire Dossier Catalyst Wire Dossier

Sodium nitroprusside in 0.9% sodium chloride

Sodium nitroprusside in 0.9% sodium chloride · Slate Run Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sodium nitroprusside in 0.9% sodium chloride, covering 2022-08-26 to 2022-08-26. Get the full timeline:

Most recent: FDA Approved: SODIUM NITROPRUSSIDE IN 0.9% SODIUM CHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)

See pricing